Sign In
Buy ABCL
$5.72
-0.410 (-6.69%)
At Close: Jun 03, 2026
AbCellera Shares Are Moving Higher On Licensing Pact With Moderna
09:31am, Wednesday, 15'th Sep 2021
AbCellera Biologics Inc (NASDAQ: ABCL) has entered into a research collaboration and license agreement with Moderna Inc (NASDAQ: MRNA) for antibodies for mRNA medicines. The collaboration will le
AbCellera to Present Virtually at the BofA Securities – Tech Solutions for Drug Discovery Conference
04:17pm, Friday, 10'th Sep 2021
VANCOUVER--(BUSINESS WIRE)---- $ABCL #antibodies--AbCellera to Present Virtually at the BofA Securities – Tech Solutions for Drug Discovery Conference
Here's Why AbCellera Biologics Stock Gained 10.6% Last Month
11:12am, Saturday, 04'th Sep 2021
Even with its recent gains, the biotech stock is down roughly 53.4% in 2021's trading.
AbCellera Biologics: I Was Wrong
10:13am, Friday, 20'th Aug 2021
AbCellera reported Q2 results on 08/12/21 which were well received by the market, sending shares up 15%. A remark by the CEO in the conference call, however, has me quite concerned. The company since
Why AbCellera Biologics Stock Was Up More Than 17% on Friday
12:52pm, Friday, 13'th Aug 2021
The biopharma company's second quarter was better than expected. The future looks pretty bright, too.
AbCellera Biologics Inc. (ABCL) CEO Carl Hansen on Q2 2021 Results - Earnings Call Transcript
09:56pm, Thursday, 12'th Aug 2021
AbCellera Biologics Inc. (ABCL) CEO Carl Hansen on Q2 2021 Results - Earnings Call Transcript
AbCellera Reports Q2 2021 Business Results
04:05pm, Thursday, 12'th Aug 2021
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL #antibodies--AbCellera Reports Q2 2021 Business Results
AbCellera Biologics: A Buy At Current Prices
04:54am, Friday, 06'th Aug 2021
AbCellera Biologics: A Buy At Current Prices
HOUSTON & VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL #antibodies--Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β Superfamily Member for the Treatm
AbCellera to Report Second Quarter 2021 Financial Results on August 12, 2021
04:05pm, Thursday, 22'nd Jul 2021
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL #antibodies--AbCellera (Nasdaq: ABCL) will announce its second quarter 2021 financial results on Thursday, August 12, 2021 and hold an earnings c
AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares
05:11pm, Thursday, 10'th Jun 2021
VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that certain entities owned and/or controlled, directly or indirectly, by Carl Hansen, Ph.D., Cofounder, Chief Ex
AbCellera Biologics: My Highest Conviction Pick, With The Longest Potential Payoff
08:44am, Monday, 31'st May 2021
I recommended AbCellera on March 8, 2021, and so far the stock has gone pretty much nowhere. However, I am as bullish as ever. Immediate catalysts are lacking, but that does not preclude you from accu
AbCellera (ABCL) Stock: Over 7% Increase Explanation
11:26am, Monday, 17'th May 2021
The stock price of AbCellera (Nasdaq: ABCL) increased by over 7% during intraday trading this morning. This is why it happened.
CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results
08:48pm, Friday, 14'th May 2021
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL #antibodies--AbCellera Reports Q1 2021 Business Results
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
11:51am, Friday, 14'th May 2021
AbCellera stock tumbled Friday, despite in-line royalties for its Lilly-partnered Covid drug. Here's why the stock toppled.
